What step in the folic acid synthesis process does trimethoprim block?

Prepare for the Drug Action 2 Exam. Focus on multiple-choice questions, learn through interactive quizzes, and understand core drug mechanisms with explanations. Dive deep into pharmacokinetics and pharmacodynamics to ace your test!

Multiple Choice

What step in the folic acid synthesis process does trimethoprim block?

Explanation:
Trimethoprim blocks the reduction step that converts dihydrofolic acid into tetrahydrofolic acid by inhibiting the bacterial enzyme dihydrofolate reductase. Without tetrahydrofolate, essential one-carbon transfers required to synthesize thymidine (a DNA building block) and purines can’t proceed, so DNA synthesis stalls and bacterial growth is halted. Sulfamethoxazole acts earlier in the pathway to prevent dihydropteroate formation, but trimethoprim’s action is specifically at the DHFR-catalyzed reduction, making this the correct description of its target. This selectivity helps explain why the drug is effective against bacteria while reducing effects on human cells, since human cells rely less exclusively on this bacterial enzyme.

Trimethoprim blocks the reduction step that converts dihydrofolic acid into tetrahydrofolic acid by inhibiting the bacterial enzyme dihydrofolate reductase. Without tetrahydrofolate, essential one-carbon transfers required to synthesize thymidine (a DNA building block) and purines can’t proceed, so DNA synthesis stalls and bacterial growth is halted. Sulfamethoxazole acts earlier in the pathway to prevent dihydropteroate formation, but trimethoprim’s action is specifically at the DHFR-catalyzed reduction, making this the correct description of its target. This selectivity helps explain why the drug is effective against bacteria while reducing effects on human cells, since human cells rely less exclusively on this bacterial enzyme.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy